计算溶液所需的质量、体积或浓度。
| 活性类型 | Relation | Activity value | Units | Action Type | 期刊 | PubMed Id | doi | Assay Aladdin ID |
|---|
提供 ≥98% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
-20°C储存。超低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
IPR-803 is a potent inhibitor of the uPAR•uPA protein-protein interaction (PPI) . IPR-803 binds directly to uPAR with sub-micromolar affinity. IPR-803 displays anti-tumor activity
In Vitro
IPR-803 blocks invasion of breast cancer cells line MDA-MB-231, and inhibits matrix metalloproteinase (MMP) breakdown of the extracellular matrix (ECM). ?\nIPR-803 impairs MDA-MB-231 cell adhesion and migration. ?\nIPR-803 induces a concentration-dependent impairment of cell adhesion with an IC 50 of approximately 30 μM. ?\nIPR-803 inhibits MDA-MB-231 cells growth with an IC 50 of 58 μM. ?\nIPR-803 (0-200 μM; 3 days) blocks the invasion of MDA-MB-231 cells, and most of the inhibition of cell invasion is unlikely due to cytotoxicity of the compound. ?\nIPR-803 (1-50 μM; 24 hours) does not have a significant effect on apoptosis or necrosis. ?\nIPR-803 (50 μM; 30 minutes) shows inhibition of MAPK phosphorylation. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Proliferation AssayCell Line: MDA-MB-231 cells Concentration: 0 μM, 50 μM, 150 μM, 200 μM Incubation Time: 3 days Result: Displays 90 percent blockage of invasion that is observed at 50 μM.
In Vivo
IPR-803 (200 mg/kg; i.g.; three times a week; for 5 weeks) impairs breast cancer metastasis, but no statistical significance to the differences in body weight between treated and untreated . ?\nIPR-803 has a low oral bioavailability at 4 percent, and remains high concentration even after 10 hours in tumor tissue . ?\nIPR-803 exhibits a half-life (t1/2) of 5 hours . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: NSG mice with MDA-MB-231 cells xenograft Dosage: 200 mg/kg Administration: Oral gavage; three times a week; for 5 weeks Result: Impaired metastasis to the lungs. Animal Model: NOD/SCID mice Dosage: 200 mg/kg (Pharmacokinetic Study) Administration: Oral administration Result: t1/2=5 hours.
Form:Solid
IC50& Target:Ki: 0.2 μM (PPI)
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 苯类化合物 |
| 类(Class) | 蒽 |
| 亚类(Subclass) | 暂无 |
| 中间层级节点(Intermediate Tree Nodes) | 暂无 |
| 直接上位类(Direct Parent) | 蒽 |
| 其他上位类(Alternative Parents) | 氨基苯甲酸 苯甲酸 苯胺和取代苯胺 芳基酮 二烷基芳胺 苯甲酰衍生物 氮杂环庚烷 芳香伯胺 乙烯基酰胺 异噁唑 杂芳族化合物 氨基酸 仲胺 氧环化合物 羧酸 氮杂环化合物 有机氧化物 碳氢化合物衍生物 |
| 分子骨架(Molecular Framework) | 芳香族杂多环化合物 |
| 取代基(Substituents) | 氨基酸 - 氨基酸 - 氨基酸或其衍生物 - 氨基苯甲酸 - 氨基苯甲酸或其衍生物 - 苯胺或取代苯胺 - 蒽醌 - 芳香族杂多环化合物 - 芳基溴化物 - 氮杂环 - 氮杂环戊烷 - 吡唑 - 苯甲酸 - 苯甲酸或衍生物 - 苯甲酰 - 羧酰胺基 - 羧酸衍生物 - 二烷基芳基胺 - 杂芳香族化合物 - 烃衍生物 - 异噁唑 - 酮 - 单环苯基基团 - 有机硝基化合物 - 有机氧化物 - 有机氧化合物 - 有机杂环化合物 - 有机氮化合物 - 有机氧化合物 - 氧杂环 - 初级芳香胺 - 醛基 - 三级脂肪族/芳香族胺 - 三芳基胺 - 乙烯酰胺 |
| 描述(Description) | 该化合物属于蒽类有机化合物。这类化合物含有三个线性并联的苯环体系。 |
| 外部描述符(External Descriptors) | 暂无 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|